From professional translators, enterprises, web pages and freely available translation repositories.
points to consider on missing data
points to consider on missing data
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
points to consider on adjustment for baseline covariates
points to consider on adjustment for baseline covariates
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
points to consider on the evaluation of diagnostic agents
points to consider on the evaluation of diagnostic agents
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
points to consider on multiplicity issues in clinical trials
points to consider on multiplicity issues in clinical trials
Last Update: 2011-10-23
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
points to consider on xenogeneic cell therapy for medicinal products
points to consider on xenogeneic cell therapy for medicinal products
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
points to consider on the assessment of anti-hiv medicinal products
points to consider on the assessment of anti- hiv medicinal products
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
not a donkey would consider that to be true
wat je zonder woorden met je gezicht uit
Last Update: 2020-11-24
Usage Frequency: 1
Quality:
Reference:
points to consider on the evaluation of diagnostic agents transmise pour consultation en novembre 2000
2000
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Reference:
Warning: This alignment may be wrong.
Please delete it you feel so.
points to consider on clinical investigation of medicinal products for the treatment of acute stroke
points to consider on clinical investigation of medicinal products in the treatment of acute stroke
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Reference:
Warning: This alignment may be wrong.
Please delete it you feel so.
points to consider on the calculation and reporting of the prevalence of a condition for orphan designation
points to consider on the calculation and reporting of the prevalence of a condition for orphan designation
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Reference:
Warning: This alignment may be wrong.
Please delete it you feel so.
concept paper on the development of a cpmp points to consider on allergic rhino-conjuctivitis.
concept paper on the development of a cpmp points to consider on allergic rhino-conjuctivitis.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Reference:
Warning: This alignment may be wrong.
Please delete it you feel so.
points to consider document on the non-clinical assessment of the carcinogenic potential of insulin analogues
points to consider document on the non-clinical assessment of the carcinogenic potential of insulin analogues
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Reference:
Warning: This alignment may be wrong.
Please delete it you feel so.
points to consider on the reduction, elimination or substitution of thiomersal in vaccines transmise pour consultation en novembre 2000
november 2000
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Reference:
Warning: This alignment may be wrong.
Please delete it you feel so.
note for guidance on photosafety testing points to consider document on the need for reproduction studies in the development of insulin analogues
points to consider document on the need for reproduction studies in the development of insulin analogues
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Reference:
Warning: This alignment may be wrong.
Please delete it you feel so.
concept paper on the development of a cpmp points to consider on the evaluation of the pharmacokinetics of medicinal products in the paediatric population.
concept paper on the development of a cpmp points to consider on the evaluation of the pharmacokinetics of medicinal products in the paediatric population.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Reference:
Warning: This alignment may be wrong.
Please delete it you feel so.
concept paper on the development of a cpmp points to consider on methodological issues in confirmatory clinical trials with flexible design and analysis plan.
concept paper on the development of a cpmp points to consider on methodological issues in confirmatory clinical trials with flexible design and analysis plan.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Reference:
Warning: This alignment may be wrong.
Please delete it you feel so.
concept paper on the development of a cpmp points to consider document on the evaluation of new anti-fungal agents for invasive fungal infections
concept paper on the development of a cpmp points to consider document on the evaluation of new anti-fungal agents for invasive fungal infections
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Reference:
Warning: This alignment may be wrong.
Please delete it you feel so.
choice of non-inferiority margin points to consider on biostatistical/ methodological issues arising from cpmp discussion on licensing applications:
choice of non-inferiority margin points to consider on biostatistical/methodological issues arising from cpmp discussion on licensing applications:
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Reference:
Warning: This alignment may be wrong.
Please delete it you feel so.
points to consider on the clinical development of fibrinolytic medicinal products in the treatment of patients with st segment elevation acute myocardial infarction (stemi)
points to consider on the clinical development of fibrinolytic medicinal products in the treatment of patients with st segment elevation acute myocardial infarction (stemi)
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Reference:
Warning: This alignment may be wrong.
Please delete it you feel so.
points to consider on clinical investigation of medicinal products for pro- phylaxis of intra- and post-operative venous thromboembolic risk adoptée en juin 2000
aangenomen in juni 2000
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Reference:
Warning: This alignment may be wrong.
Please delete it you feel so.